Compound Summary
Compound Name: | parthenolide |
Compound CID: | 7251185 |
Synonyms: | parthenolide 20554-84-1 (-)-Parthenolide MFCD00134592 CHEBI:7939 More... |
Iupac Name: | (1S,2R,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one |
InChI: | InChI=1S/C15H20O3/c1-9-5-4-8-15(3)13(18-15)12-11(7-6-9)10(2)14(16)17-12/h5,11-13H,2,4,6-8H2,1,3H3/b9-5+/t11-,12-,13+,15+/m0/s1 |
InChIKey: | KTEXNACQROZXEV-PVLRGYAZSA-N |
Canonical Smiles: | CC1=CCCC2(C(O2)C3C(CC1)C(=C)C(=O)O3)C |
Isomeric Smiles: | C/C/1=C\CC[C@@]2([C@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C |
Molecular Weight: | 248.32 |
Molecular Formula: | C15H20O3 |
Molecular Weight: | 248.32 |
Molecular Formula: | C15H20O3 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 18 |
Complexity: | 437 |
parthenolide | parthenolide |
---|---|
parthenolide |
20554-84-1 |
(-)-Parthenolide |
MFCD00134592 |
CHEBI:7939 |
4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone |
(1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno9,10cyclodeca1,2-bfuran-9(1aH)-one |
29552-41-8 |
partenolide |
Parthenolide, Tanacetum parthenium |
Oxireno9,10cyclodeca1,2-bfuran-9(1aH)-one, 2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methylene-, (1aR,4E,7aS,10aS,10bR)- |
Prestwick2_000550 |
Prestwick3_000550 |
Epitope ID:115014 |
SCHEMBL8220 |
BSPBio_000599 |
BSPBio_001308 |
MLS002153872 |
BPBio1_000659 |
CHEMBL465158 |
parthenolide-(alternate-stereo) |
SCHEMBL13367522 |
BCBcMAP01_000041 |
Parthenolide, >=98% (HPLC) |
HMS1361B10 |
HMS1569N21 |
HMS1791B10 |
HMS1989B10 |
HMS2096N21 |
HMS3402B10 |
HMS3713N21 |
BCP10404 |
EX-A5460 |
HY-N0141 |
ZINC4492886 |
AKOS016010226 |
CCG-208244 |
CS-1919 |
IDI1_033778 |
NCGC00163415-01 |
NCGC00163415-04 |
AS-17479 |
SMR001233226 |
AB0019832 |
AB00513860 |
V0355 |
552P418 |
Q-100253 |
(-)-Parthenolide; NSC-157035; NSC 157035; NSC157035 |
Parthenolide, United States Pharmacopeia (USP) Reference Standard |
(3aS,10R,11R,11aS,6E)-3-Methylene-6,10-dimethyl-10,11-epoxy-1-oxa-2,3,3a,4,5,8,9,10,11,11a-decahydro-1H-cyclopentacyclodecene-2-one |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | -11.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | -11.000000000000000 | 1 | 1 |